The MGMT promoter methylation LASSO regression (predicting glioblastomas with methylated MGMT promoters compared to controls) yielded 91% sensitivity and 73% specificity for the test dataset, using 17 of 569 genes (Figure 4) (Supplementary Table S2). Here, MGMT is linked to glioblastoma.